Company: Daiichi Sankyo
Job title: Scientist
Daisuke Okajima received his master’s degree in Agriculture from Kyoto University and joined Daiich Pharmaceutical Co., Ltd. in 2001. He received his Ph.D. in Bioscience from Tsukuba University in 2011 and has been working on ADC research at Daiichi Sankyo Co., Ltd. since 2012. Now he is a representative of preclinical pharmacology in DS-1062 project, which is one of the key projects in the DXd-ADC pipeline.
DS-1062, a TROP2-targeting ADC with a Novel DNA Topoisomerase Inhibitor 9:10 am
DXd-ADC: Widely applicable technology platform Preclinical results on the mechanism of action of DS-1062 Updates on clinical development of DS-1062Read more
day: Day One